SVs can drive cancer development by affecting oncogenes, tumor suppressor genes, and regulatory regions of the genome. For instance, a deletion might remove a tumor suppressor gene, while a duplication might amplify an oncogene. Translocations can create fusion genes with novel properties that promote uncontrolled cell growth.
